Back in Time: The Huey Lewis Effect Meets the Telomere Effect
If you grew up in the 80s, you probably remember Huey Lewis and the News belting out “Back in Time” as Marty McFly gunned the DeLorean up to 88 miles per hour. It turns out that, forty years later, scientists might be trying to do the same thing—just not with plutonium or flux capacitors. Instead, they’re tinkering with something even smaller: the end caps on your DNA.
Those end caps are called telomeres, and they’re a bit like the plastic tips on shoelaces—there to protect the ends from fraying. Each time a cell divides, the telomeres get a little shorter. Eventually, they wear down to a critical length, and the cell stops dividing or dies. This is one of the fundamental processes of biological aging—the reason why our tissues lose elasticity, our metabolism slows, and our joints sound like bubble wrap when we stand up.
But here’s where things get interesting: scientists are learning how to re-lengthen those telomeres. In 2015, a team at Stanford University made headlines when they used a modified form of messenger RNA to temporarily activate telomerase—the enzyme that rebuilds telomeres. In their lab, human skin cells didn’t just stop aging; they actually looked 20 years younger on a molecular level. The treated cells could divide up to forty more times than before, essentially rewinding the cellular clock. It wasn’t exactly Back to the Future, but it was close enough to get Hollywood’s attention.
Fast-forward to today (pun intended), and the science has evolved. Newer studies are exploring circular RNA versions of telomerase that seem to work even better in regenerating cells affected by premature aging syndromes. Others have moved the research into early human testing—focusing on people with genetic disorders that cause accelerated telomere loss. The results so far are promising: elongated telomeres, more robust cell function, and fewer markers of cellular senescence.
Before you start checking Zillow for property in the Fountain of Youth district, it’s important to note one thing: none of this has been done in healthy humans yet. These breakthroughs are happening in petri dishes and, in a few cases, in patients with rare genetic diseases. We don’t yet know how telomere extension might affect fully functioning adult systems—or whether making telomeres too long could actually increase cancer risk by letting damaged cells live longer than they should. In other words, this is still basic science, not a beauty treatment.
That said, it’s hard not to get excited. We’re entering a moment when aging itself is becoming a treatable condition—not science fiction, but science in motion. Between telomere therapies, stem-cell rejuvenation, CRISPR gene editing, and cellular reprogramming, biotech is quietly building tools that could reshape how long and how well we live. The timeline might not be 1.21 gigawatts fast, but the trajectory is undeniable.
So no, you can’t yet buy a telomere-lengthening cream at CVS or a subscription to “Youth 2.0.” But the fact that researchers are now reversing the biological age of human cells is remarkable on its own. It’s proof that the line between medicine and miracle is getting blurry.
And that’s exactly why biotech remains one of the most fascinating—and investable—sectors out there. The potential isn’t just in curing disease; it’s in redefining what it means to age. So buckle up, because if Huey Lewis was right and “it’s hip to be square,” then it’s about to be even hipper to grow younger.
Cue the guitar riff.🎸